Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis
Kancheng He, Huating Hu, Senlin Ye, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Obesity, Diabetes, and Increased Cancer Progression
Dae-Seok Kim, Philipp E. Scherer
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 6, pp. 799-812
Open Access | Times Cited: 167
Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
Maddison Archer, Navneet Dogra, Natasha Kyprianou
Cancers (2020) Vol. 12, Iss. 10, pp. 2984-2984
Open Access | Times Cited: 102
Insulin Resistance and Cancer: In Search for a Causal Link
Eusebio Chiefari, Maria Mirabelli, Sandro La Vignera, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11137-11137
Open Access | Times Cited: 91
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Abraham Pedroza‐Torres, Sandra Romero‐Córdoba, Montserrat Justo-Garrido, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 79
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Moein Ala, Mahan Ala
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 6, pp. 1747-1770
Open Access | Times Cited: 65
Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: Reversing mitochondrial dysfunction and upregulating glyoxalase 1
Ponarulselvam Sekar, George Hsiao, Shu‐Hao Hsu, et al.
Redox Biology (2023) Vol. 64, pp. 102786-102786
Open Access | Times Cited: 38
Targeting lipid metabolism in metastatic prostate cancer
Tahlia Scheinberg, Blossom Mak, Lisa M. Butler, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 24
Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
Marc Pujalte‐Martin, Amine Belaïd, Simon Bost, et al.
Molecular Oncology (2024) Vol. 18, Iss. 7, pp. 1719-1738
Open Access | Times Cited: 16
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence
Anqi Lin, Yanxi Ding, Zhengrui Li, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
Hyun Kyu Ahn, Young Hwa Lee, Kyo Chul Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8540-8540
Open Access | Times Cited: 69
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Daniel J. Turnham, Nicholas Bullock, Manisha S. Dass, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 62
The Use of Metformin to Increase the Human Healthspan
Veronika Piskovatska, Kenneth B. Storey, Alexander Vaiserman, et al.
Advances in experimental medicine and biology (2020), pp. 319-332
Closed Access | Times Cited: 52
Biguanides: Species with versatile therapeutic applications
Deepika Kathuria, Akshay D. Raul, Pravin J. Wanjari, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113378-113378
Closed Access | Times Cited: 51
TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability
Surbhi Chouhan, Mithila Sawant, Cody Weimholt, et al.
Autophagy (2022) Vol. 19, Iss. 3, pp. 1000-1025
Open Access | Times Cited: 31
Cancer Metabolism as a Therapeutic Target and Review of Interventions
Matthew Halma, Jack A. Tuszyński, Paul E. Marik
Nutrients (2023) Vol. 15, Iss. 19, pp. 4245-4245
Open Access | Times Cited: 20
Associations between Diabetes Mellitus and Selected Cancers
Monika Pliszka, Leszek Szablewski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7476-7476
Open Access | Times Cited: 8
Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
Takuji Hayashi, Kazutoshi Fujita, Makoto Matsushita, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1153-1153
Open Access | Times Cited: 49
The effect of periodontal bacteria infection on incidence and prognosis of cancer
Xiao Li, Qianyu Zhang, Yanshuang Peng, et al.
Medicine (2020) Vol. 99, Iss. 15, pp. e19698-e19698
Open Access | Times Cited: 49
The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
Kang Xiao, Fengxi Liu, Juan Liu, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 4, pp. 783-792
Open Access | Times Cited: 46
Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer
Benjamin C. Fu, Fred K. Tabung, Claire H. Pernar, et al.
European Urology (2021) Vol. 79, Iss. 3, pp. 405-412
Open Access | Times Cited: 38
Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Guadalupe R. Fajardo-Orduña, Edgar Ledesma-Martínez, Itzen Aguíñiga-Sánchez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4955-4955
Open Access | Times Cited: 28
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
Brooke E. Wilson, Andrew J. Armstrong, Johann S. de Bono, et al.
European Journal of Cancer (2022) Vol. 170, pp. 296-304
Open Access | Times Cited: 21
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
Jan Beneš, Martin Kotrč, Katerina Kroupova, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk
Xiaohui Sun, Jie Ping, Xingyi Guo, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 849-858
Closed Access | Times Cited: 4
Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C
Yuan Fang, Cong Cheng, Fei‐Yan Xiao, et al.
Life Sciences (2020) Vol. 243, pp. 117276-117276
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top